Structure and function of G protein‐coupled receptor oligomers: implications for drug discovery

Abstract

G protein‐coupled receptor (GPCR) oligomers are promising targets for the design of new highly selective therapeutics. GPCRs have historically been attractive drug targets for their role in nearly all cellular processes, and their localization at the cell surface makes them easily accessible to most small molecule therapeutics. However, GPCRs have traditionally been considered a monomeric entity, a notion that greatly oversimplifies their function. As evidence accumulates that GPCRs tune function through oligomer formation and protein–protein interactions, we see a greater demand for structural information about these oligomers to facilitate oligomer‐specific drug design. These efforts are slowed by difficulties inherent to studying membrane proteins, such as low expression yield, in vitro stability and activity. Such obstacles are amplified for the study of specific oligomers, as there are limited tools to directly isolate and characterize these receptor complexes. Thus, there is a need to develop new interdisciplinary approaches, combining biochemical and biophysical techniques, to address these challenges and elucidate structural details about the oligomer and ligand binding interfaces. In this review, we provide an overview of mechanistic models that have been proposed to underlie the function of GPCR oligomers, and perspectives on emerging techniques to characterize GPCR oligomers for structure‐based drug design. WIREs Nanomed Nanobiotechnol 2015, 7:408–427. doi: 10.1002/wnan.1319 This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology

Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors

“…Fine tuning of GPCR function through protein-protein interactions ( e.g . homomerization or heteromerization) would comprise ligand interactions, cellular trafficking, and mobility [114, 115].…”

Visualizing the GPCR Network: Classification and Evolution

“…The conformational changes of GPCRs upon ligand binding activate the associated G protein to initiate a series of biochemical reactions within the cell. These intracellular reactions regulate a wide variety of physiological functions, such as smell, taste, vision, secretion, neurotransmission, metabolism, cellular differentiation and growth, inflammatory and immune response 4 – 6 . Consequently, malfunction of GPCR signaling pathways can cause various diseases, including cancer, diabetes, obesity, inflammation, cardiac dysfunction, and central nervous system disorders.…”

Adenosine A2a receptors form distinct oligomers in protein detergent complexes

“…Localized at the cell surface, they are easily accessible to extracellular therapeutics that activate or inhibit associated intracellular reaction cascades, making them ideal pharmaceutical targets . The motivation for this study is rooted in increasing evidence that many GPCRs tune their function by forming homo‐ or heteromeric oligomer complexes, spurring the development of novel therapeutics tailored to associate with specific oligomers . However, experimental difficulties stemming from low overall abundance , dynamic flexibility , and poor stability in membrane mimetic systems have hindered biophysical insight into the stability and structure‐function of membrane protein oligomers, especially that of GPCRs.…”